ASPC SEC filings, in plain English
Everything ASPAC III Acquisition Corp. has filed with the SEC that we hold — 40 filings, newest first, 40 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: A routine regulatory quarterly report (Form 10-Q) filed by A SPAC III Acquisition Corp. for the fiscal quarter ended June 30, 2026. The filing reports that 5,717,419 public shares were redeemed for $59,502,058 following shareholder approval at the October 2025 Extraordinary General Meeting, leaving 282,581 redeemable shares valued at $3,032,747 ($10.73 per share) as of June 30, 2026. Management confirms the business combination deadline was formally extended to November 12, 2026. On January 16, 2026, the Sponsor transferred and delivered 1,499,900 Class B ordinary shares to the Company in exchange for 1,499,900 Class A ordinary shares, resulting in the Sponsor holding approximately 76.4% of outstanding Class A shares. According to subsequent event disclosures, Nasdaq notified the Company on May 20, 2026 of a deficiency for failing to maintain $2,500,000 in stockholders’ equity; the Company submitted a compliance plan on July 1, 2026, which Nasdaq accepted on July 17, 2026, granting an extension until November 12, 2026. For the six months ended June 30, 2026, management reports a net loss of $(129,206), remaining cash of $633,724, and working capital of $237,744. The contingent merger with Bioserica International Limited under an agreement dated May 23, 2025, totaling $217,860,000, remains pending, while a prior indication of interest with HDEducation Group Limited was terminated on May 21, 2025. Why it matters: This filing materially updates redemption mechanics by confirming the public float shrank to 282,581 shares, with trust value per share settled at $10.73 rather than the standard $10.00 baseline, indicating accrued interest offsets potential dissolution allowances. The Nasdaq equity compliance window expires concurrently with the business combination deadline, making successful deal closure the sole mechanism to avoid delisting and mandatory liquidation. The Sponsor’s intra-period share exchange consolidates voting and economic control ahead of any shareholder vote on the Bioserica transaction. Per management’s going concern assessment, the company lacks operating revenue, relies on $1,600,217 in previously incurred transaction costs and off-trust liquidity, and discloses no customer concentrations, sector-specific market sizing, or technology developments beyond its stated ESG and material technology mandate.
trust account, combination deadline, going-concern doubt +1nothing moved · 4 with no prior record of ours
- Trust account
- $60.0M · unchanged
- Combination deadline
- 2026-11-12 · unchanged
- Going-concern doubt
- stated · unchanged
- Redeemable shares
- 283K · unchanged
The clause …“units ($50,000) was placed in the Trust Account, resulting in a total of $60,000,000 held in the Trust Account. As of November 19, 2024, a total of $60,000,000 ($10.00 per unit) of the net proceeds from the IPO and the Private”…
The clause …“extensions). There is no assurance that the Company’s plans to consummate a Business Combination will be successful by November 12, 2026. If the Company does not complete a Business Combination, the Company’s board of directors would”…
The clause “Standards “Codification Subtopic 205-40, Presentation of Financial Statements - Going Concern”, management has determined that the mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, along”…
The clause …“and 555,000 shares issued and outstanding (excluding 282,581 shares and 282,581 shares subject to possible redemption) as of June 30, 2026 and December 31, 2025, respectively — — Class B ordinary shares, no par value; 10,000,000”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: SEC Form 8-K, Item 3.01: Routine compliance exhibit reporting a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 20, 2026, Nasdaq notified the Company that its reported stockholders’ equity in the Form 10-Q for the fiscal quarter ended March 31, 2026 fell below the $2,500,000 Minimum Stockholders’ Equity Requirement under Nasdaq Listing Rule 5550(b)(1). The filing establishes a 45-calendar-day deadline to submit a remediation plan and notes that Nasdaq may grant a further 180-calendar-day extension upon acceptance of that plan. The disclosure contains no amendments to the redemption calendar, updates to the per-share trust balance, announced extension proposals, identified merger targets, or sponsor conduct adjustments. Why it matters: A continued listing deficiency directly restricts secondary market liquidity for ASPC and complicates capital formation or financing activities required while the SPAC operates in a SEARCHING status ahead of the November 12, 2026 termination date. The sub-$2,500,000 equity reading signals net asset depletion or sustained administrative burn rate relative to the trust and warrant/rights balances, elevating the probability that shareholder capital may be impaired or that liquidation mechanics may be triggered earlier than scheduled. Nasdaq’s compliance framework imposes strict procedural gates; failure to file within 45 calendar days or to demonstrate recovery during an approved extension window forces formal delisting execution. Chief Executive Officer and Chief Financial Officer Claudius Tsang signed the report and confirmed management is drafting the compliance proposal to submit within the allotted timeframe, while the registrant expressly warns there is no assurance equity will rebound or that Nasdaq will approve the remedial strategy.
What changed: This document is a Form 10-Q quarterly report filed by A SPAC III Acquisition Corp. for the period ended March 31, 2026. Management discloses that the Trust Account held $3,006,138 as of March 31, 2026, setting a current redemption value of $10.64 per share for the 282,581 Class A ordinary shares subject to possible redemption. The Company's Combination Period is set to expire on November 12, 2026, following a shareholder-approved extension approved in October 2025. In terms of deal progress, the Merger Agreement with Bioserica International Limited (dated May 23, 2025) remains the active transaction framework, stipulating aggregate consideration of $217,860,000 payable in 20,000,000 PubCo Class B shares and 1,786,000 PubCo Class A shares. A separate preliminary agreement with HDEducation Group was terminated by mutual consent in May 2025. Why it matters: Pursuant to filings by management, the Sponsor completed a Share Exchange on January 16, 2026, transferring 1,499,900 Class B ordinary shares to the Company in exchange for an identical number of Class A shares. Consequently, the Sponsor now controls approximately 76.4% of the Company’s 2,337,581 outstanding ordinary shares, substantially increasing sponsor leverage over the diminished public float as the November 12, 2026 deadline approaches. Management explicitly states that ongoing operating expenditures—specifically $53,780 in general and administrative expenses and $93,400 in legal and professional expenses for the quarter—combined with limited non-operating interest income of $33,192 resulted in a net loss of $113,988. Per management's assessment, these conditions raise substantial doubt about the Company's ability to continue as a going concern, meaning failure to close the Bioserica transaction (or pursue an alternative) before the expiration date will trigger a mandatory voluntary liquidation and redistribution of the Trust Account.
What changed vs 2025-11-10trust $62.3M → $60.0M -4%shares 6.00M → 283K -95%trust account, redeemable shares, combination deadline +22 moved · 3 with no prior record of ours
- Trust account
- $62.3M$60.0M
- Redeemable shares
- 6.00M283K
- Combination deadline
- 2026-11-12 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $276Knot matched in this filing
SpacBrain reads this as $2,268,671 left the trust between the two filings.
The clause …“units ($50,000) was placed in the Trust Account, resulting in a total of $60,000,000 held in the Trust Account. As of November 19, 2024, a total of $60,000,000 ($10.00 per unit) of the net proceeds from the IPO and the Private”…
SpacBrain reads this as 5,717,419 shares are no longer redeemable.
The clause …“and 555,000 shares issued and outstanding (excluding 282,581 shares and 282,581 shares subject to possible redemption) as of March 31, 2026 and December 31, 2025, respectively — — Class B ordinary shares, no par value; 10,000,000”…
The clause …“extensions). There is no assurance that the Company’s plans to consummate a Business Combination will be successful by November 12, 2026. If the Company does not complete a Business Combination, the Company’s board of directors would”…
The clause …“and potential subsequent dissolution, as well as liquidity concerns raise substantial doubt about the Company’s ability to continue as a going concern. Therefore, management believes that it would be prudent to include in its”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 8-K Current Report accompanying Exhibit 99.1, an PFIC Annual Information Statement for the fiscal year ended December 31, 2025. Under Item 8.01, the registrant made its passive foreign investment company tax disclosures available to Class A ordinary share holders. The attached exhibit states that 'significant changes in the number of shares outstanding during the taxable year' occurred due to shareholder redemptions. It records 8,055,000 shares outstanding from January 1, 2025 through October 26, 2025, followed by a drop to 2,337,581 shares from October 27, 2025 through December 31, 2025. To support Qualified Electing Fund tax elections, the company provides per-share, per-day ordinary earnings of $0.000616487 for the first segment and $0.002124334 for the second segment, with net capital gains listed as NONE for both. Why it matters: The segmentation confirms ongoing and substantial investor redemptions ahead of the documented November 12, 2026 liquidation deadline, meaning remaining trust balance will be allocated across a smaller pool of 2,337,581 units rather than the initial public float size. The filing contains no announcement of a merger, extension amendment, or business combination target; CEO and CFO Claudius Tsang executed the report solely to satisfy routine cross-border tax reporting for U.S. persons. Holders must apply these exact time-segmented yields to calculate their pro rata earnings and complete IRS Form 8621, though the company strongly recommends consulting independent tax advisors regarding PFIC consequences.
What changed: Annual Report on Form 10-K. The filing discloses that the business combination deadline was extended to November 12, 2026 following a shareholder vote on October 27, 2025 that triggered the redemption of 5,717,419 Class A ordinary shares for $59,502,058. As a result, the Trust Account balance fell to $2,979,936, covering only 282,581 remaining public shares. Target pursuit shifted from a terminated HDEducation Group indication to a Merger Agreement executed May 23, 2025 with Bioserica International Limited, setting aggregate consideration at $217,860,000 in PubCo equity, subject to a prerequisite $12,500,000 third-party investment before closing. On January 16, 2026, the Sponsor completed a share exchange transferring 1,499,900 Class B ordinary shares to the Company for 1,499,900 Class A ordinary shares, consolidating its ownership to approximately 76.4%. The Sponsor also transferred an economic interest in 100,000 Class B ordinary shares to an unaffiliated third party to secure voting commitments for 621,084 public shares supporting the extension. Why it matters: The withdrawal of $59,502,058 left a residual trust pool of $2,979,936 to satisfy the remaining 282,581 shareholders, heavily compressing per-share distribution expectations and concentrating post-extension liquidation risk among a tiny shareholder base. The $217,860,000 Bioserica acquisition carries heavy execution uncertainty, relying on a $12,500,000 PIPE that remains unfunded and navigating extensive PRC regulatory exposures, including VIE contract enforceability, cybersecurity review thresholds, and CSRC filing mandates. Management explicitly flagged substantial doubt regarding the company's ability to continue as a going concern through the November 12, 2026 cutoff, marking a high-probability liquidation trajectory absent a ratified merger. Concurrently, the Sponsor's share conversion and proxy-assignment mechanics concentrate voting control, stripping public float and fundamentally rewriting the equity calculus for any future business combination approval.
What changed vs 2025-03-05deadline 2026-05-12 → 2026-11-12combination deadline, trust account, going-concern doubt +31 moved · 5 with no prior record of ours
- Combination deadline
- 2026-05-122026-11-12
- Trust account
- $60.4M · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $276K · unchanged
- Mandate language
- we intend to focus on businesses in the Environmental, Susta… · unchanged
- Redeemable shares
- 6.00Mnot matched in this filing
SpacBrain reads this as 184 days later than the previous record.
The clause …“extensions). There is no assurance that the Company’s plans to consummate a Business Combination will be successful by November 12, 2026. If the Company does not complete a Business Combination, the Company’s board of directors would”…
The clause …“unobservable inputs 2024 (Level 1) (Level 2) (Level 3) Assets Investments held in Trust Account $ 60,356,959 $ 60,356,959 — — F- 18 Note 9 — Segment Information ASC Topic 280, “Segment Reporting,” establishes standards for companies”…
The clause “Combination will be successful. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of”…
The clause “Note on January 24, 2025. As of December 31, 2025 and 2024, there were nil and $ 276,221 outstanding under the Promissory Note, respectively. Working Capital Loans In addition, in order to finance transaction costs in connection with an”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Schedule 13G/A, which is an amended beneficial ownership report filed by Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. The filing updates the beneficial ownership disclosure for the named Bank of Montreal affiliates. Regarding SPAC mechanics, the document confirms no changes to the trust account valuation of $10.73 per share, the November 12, 2026 redemption deadline, or the SEARCHING status. There are no reported amendments to extension provisions, acquisition target negotiations, or sponsor governance arrangements. Why it matters: For investors monitoring redemption calendars and trust preservation, this is a standard post-initial-offering compliance submission that leaves capital structure and execution timelines unaltered. The filing contains zero substantive business claims; the reporting parties do not disclose positions regarding revenue, customer contracts, market opportunity, proprietary technology, strategic partnerships, ongoing litigation, or executive personnel changes. Any inference about institutional positioning rests on standard regulatory reporting conventions rather than explicit statements by the filers.
What changed: Limited Power of Attorney exhibits (Exhibit A and Exhibit B) executed as part of a Schedule 13G/A amendment. This document contains no updates regarding ASPC’s redemption deadline, trust share value, extension mechanisms, business combination progress, or sponsor conduct. It functions strictly as an internal corporate authorization for institutional reporting. Why it matters: Mizuho Financial Group, Inc. declares through this filing that it and its subsidiaries—Mizuho Bank, Ltd. (principal office: 1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan; classified as A non-U.S. institution equivalent to Bank), Mizuho Americas LLC (principal office: 1271 Avenue of the Americas, NY, NY 10020, USA; classified as A parent holding company), and Mizuho Securities USA LLC (principal office: 1271 Avenue of the Americas, NY, NY 10020, USA; classified as A registered Broker-Dealer)—maintain a reportable beneficial ownership interest in ASPC necessitating Schedule 13G disclosure. Hidekatsu Take (Deputy President & Corporate Executive; Managing Executive Officer, Head of Global Corporate & Investment Banking Division, Head of Global Transaction Banking Unit) and Adam Hopkins (Chief Legal Officer; Managing Director, General Counsel) grant full execution authority over Form 13G filings to Takahiro Katsura (Managing Director, Head of Global Branches & Subsidiaries Coordination Office, Global Corporate Function Coordination Department). The document makes no claims regarding ASPC’s customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: A Schedule 13G/A beneficial ownership report attributed to W. R. Berkley Corporation and Berkley Insurance Company. The filing text contains no disclosed changes to share quantities, ownership percentages, or transaction dates. Regarding redemption deadlines, trust value per share, extension provisions, target business development, or sponsor conduct, the excerpt provides no operational updates, amended tables, or mechanical triggers affecting investor protections or capital allocation. Why it matters: Under SEC rules, a Schedule 13G/A typically signals a post-threshold adjustment in aggregate beneficial ownership, which could indicate shifting institutional positioning ahead of a redemption window or combination vote. Because the submitted text omits the mandatory ownership schedules, purpose-of-purchase declarations, and exact share counts, no concrete shift in voting leverage or liquidity pressure can be verified from this excerpt alone. The document also contains no substantive claims regarding customers, revenue, market size, corporate strategy, technology, partnerships, litigation exposure, or executive personnel.
What changed: This document is a Joint Filing Statement pursuant to Rule 13D-1(k)(1), attached as Exhibit I to a Schedule 13G/A, executed by ATW SPAC Management LLC, Kerry Propper, and Antonio Ruiz-Gimenez on February 06, 2026, consenting to the joint submission of their beneficial ownership reports regarding shares of A SPAC III Acquisition Corp. The filing text contains no amended share quantities, ownership percentages, acquisition or disposition dates, or revised purpose statements. It solely records that the three named parties authorize a single Schedule 13G on their collective behalf. Consequently, there is no reported change in beneficial ownership, no modification to prior disclosure positions, and no operational development impacting ASPAC III’s SEARCHING status, its prevailing trust mechanics, or its active redemption timeline. Why it matters: For investors monitoring redemption calendars, extension procedures, business combination progress, or sponsor conduct, this exhibit is procedurally neutral. It introduces no triggers for trust distributions, conversion events, or shareholder votes. The signatories’ mutual consent language reflects routine compliance housekeeping designed to reduce filing burdens for the founding group. The text makes no claims regarding customer relationships, revenue streams, market size, strategic initiatives, technological capabilities, partnership arrangements, ongoing litigation, or executive personnel shifts. All procedural descriptions and consent assertions derive exclusively from the executed statements of the three parties.
What changed: SEC Form 8-K Current Report disclosing an unregistered sale of equity securities pursuant to Item 3.02. According to an Exchange Agreement dated January 16, 2026, and executed by Chief Executive Officer Claudius Tsang, the Sponsor transferred and delivered 1,499,900 Class B ordinary shares to the Company in exchange for 1,499,900 Class A ordinary shares. The registrant states that following this Share Exchange, there are 2,337,481 Class A Shares and 100 Class B Shares issued and outstanding. The filing reports that the Sponsor now holds approximately 76.4% of the Company’s outstanding Class A Shares. The registrant further discloses that these exchanged Class A Shares inherit the exact restrictions previously attached to the Class B shares, specifically transfer limitations, a waiver of redemption rights, and a binding obligation to vote in favor of an initial business combination. The Company attributes the issuance to the Section 3(a)(9) registration exemption. Why it matters: The transaction mechanically reduces the tradable share count by moving 1,499,900 units from the Sponsor’s restricted pool into the public float while permanently stripping those specific shares of redemption eligibility and mandating affirmative merger votes. While the filing contains no updated metrics regarding the trust account or search timeline, the disclosed 76.4% Sponsor concentration fundamentally tightens the shareholder redemption calculus ahead of period expiration. Tracking investors should note this structural consolidation as a defensive measure to preserve trust capital and secure management backing for a future business combination, rather than an announcement of deal progress.
What changed: Joint Filing Statement pursuant to Rule 13D-1(k)(1) attached to a Schedule 13G/A beneficial ownership report. The exhibit provides only administrative consent language permitting Boothbay Fund Management LLC, Boothbay Absolute Return Strategies, LP, and Ari Glass to file a single Schedule 13G on their collective behalf. It discloses zero adjustments to beneficial ownership thresholds, introduces no amendments to reporting periods, and contains no language altering redemption windows, trust account calculations, de-spacification deadlines, or sponsor governance protocols. Why it matters: As a purely procedural compliance attachment required by the Securities Exchange Act of 1934, the document carries no operational or financial weight for SPAC tracking. It does not signal shifts in institutional positioning that would presage a shareholder vote, nor does it reference customer contracts, revenue metrics, total addressable markets, product roadmaps, technology IP, commercial partnerships, litigation exposures, or executive personnel changes beyond identifying Ari Glass as Managing Member consenting to the filing mechanism. For investors monitoring redemption calendars, trust value, or acquisition progress, this exhibit registers as a routine regulatory formality with no substantive impact on capital structure mechanics or shareholder rights.
What changed: An Amendment to Schedule 13G (beneficial ownership report) accompanied by an Exhibit I Joint Filing Statement pursuant to Rule 13D-1(k)(1). The filing establishes a joint filing arrangement among ATW SPAC Management LLC, Kerry Propper, and Antonio Ruiz-Gimenez for their beneficial ownership reporting of shares in ASPAC III Acquisition Corp. The Exhibit I text expressly consents to combined reporting under the Securities Exchange Act of 1934, incorporates the joint statement into the Schedule 13G, and stipulates that the arrangement may be terminated by any signatory upon written notice or mutually agreed lesser period. No amendments to reported share quantities, acquisition purposes, or reporting thresholds appear in the provided excerpt. Why it matters: This document bears no bearing on redemption deadlines, trust value, extension votes, deal progress, or sponsor conduct. It is purely an administrative compliance update confirming shared reporting responsibility among the current beneficial owners. The filing contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The only statements made are the administrative consent and termination provisions explicitly attributed by the signatories, Kerry Propper (identified as Co-Managing Member) and Antonio Ruiz-Gimenez.
What changed: A Schedule 13G/A, which is an amended beneficial ownership report filed with the SEC to update disclosures regarding equity holdings in a class of securities. The excerpt identifies only the filing designation, accession number, and three reporting entities: Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. No share quantities, ownership percentages, transaction dates, pricing, or stated investment purposes are disclosed in the text. Why it matters: This filing conveys no updates to redemption deadlines, trust values, extension procedures, business combination progress, or sponsor conduct. While amended 13Gs frequently mark institutional portfolio adjustments, the absence of quantitative disclosures or purpose clauses prevents determination of whether the reporting parties are passively holding shares, executing market-making activities, or positioning relative to a prospective merger vote. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; the named entities are financial institutions and brokerage affiliates rather than operating principals issuing material representations.
What changed: This is a Quarterly Report on Form 10-Q for A SPAC III Acquisition Corp., covering the fiscal quarter ended September 30, 2025. Per Note 10 of the filing, shareholders voted on October 27, 2025, to extend the business combination deadline to November 12, 2026. Simultaneously, 5,717,419 Class A ordinary shares were redeemed for $59,502,057, reducing the Trust Account to approximately $2.9 million and increasing Sponsor ownership to approximately 76.4% of the 2,337,581 total outstanding shares. Management also confirmed the January 24, 2025, full repayment of a $276,221 promissory note. Separately, the filing outlines a May 23, 2025, Merger Agreement with Bioserica International Limited pricing the transaction at $217,860,000 ($200,000,000 via newly issued Class B shares and $17,860,000 via Class A shares), contingent upon securing $12,500,000 in third-party investment. As of September 30, 2025, investments held in the Trust Account were valued at $62,268,671, while off-Trust cash balances stood at $1,062,632. Why it matters: The extraordinary redemption rate stripped the Trust of nearly all capital, leaving the Sponsor-controlled entity with diminished liquidity and triggering management's explicit going concern warning. The extension to November 12, 2026, preserves time to close, but public holders bear concentrated risk given the residual sub-$3 million cash cushion and the heavy reliance on the conditional $12,500,000 external funding for the Bioserica acquisition to proceed. Investors should track whether the remaining reserves suffice to cover transaction expenses before the revised deadline.
What changed vs 2025-08-13trust $61.6M → $62.3M +1%deadline 2025-11-12 → 2026-11-12trust account, combination deadline, going-concern doubt +22 moved · 3 with no prior record of ours
- Trust account
- $61.6M$62.3M
- Combination deadline
- 2025-11-122026-11-12
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $276K · unchanged
- Redeemable shares
- 6.00M · unchanged
SpacBrain reads this as $643,824 was added to the trust between the two filings.
The clause …“expenses 29,579 116,733 Total current assets 1,092,211 1,718,199 Investments held in trust account 62,268,671 60,356,959 Total Assets $ 63,360,882 $ 62,075,158 Liabilities, Shares Subject to Redemption and Shareholders’ Equity Accounts”…
SpacBrain reads this as 365 days later than the previous record.
The clause …“which it has to consummate a business combination from November 12, 2025 to November 12, 2026 by adopting a new amended and restated memorandum and articles of association (the “New Charter”) (the “Extension Amendment Proposal”). In”…
The clause “14-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete a Business Combination within the Combination Period, then the Company”…
The clause …“24, 2025. As of September 30, 2025 and December 31, 2024, there were nil and $ 276,221 outstanding under the Promissory Note. Working Capital Loans In addition, in order to finance transaction costs in connection with an intended”…
The clause “(Note 6) Class A ordinary shares, no par value; 100,000,000 shares authorized; 6,000,000 shares subject to possible redemption as of September 30, 2025 and December 31, 2024 61,856,313 57,694,432 Shareholders’ Equity: Preference shares,”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Schedule 13G/A amendment reporting beneficial ownership. The filing states that W. R. Berkley Corporation and Berkley Insurance Company hold interests in ASPAC III Acquisition Corp. The excerpt provides no share counts, purchase prices, or voting thresholds. There is no disclosure regarding the ten dollar seventy three cent trust value, the November twelve twenty twenty six deadline, any business combination search activity, extension proposals, redemption mechanics, or sponsor behavior. Why it matters: Beneficial ownership amendments reveal institutional positioning within a SEARCHING SPAC. Tracking firms like W. R. Berkley Corporation and Berkley Insurance Company helps investors map future voting alignments for potential combination approvals or trust extensions. Without explicit position metrics or intent declarations in this excerpt, the actual impact on shareholder turnout, trust preservation, or deal execution remains unquantifiable.
What changed: Joint Filing Agreement (Exhibit 99.2) attached to a Schedule 13G/A covering Class A Ordinary shares of ASPAC III Acquisition Corp. According to Feis Equities LLC and Lawrence M. Feis, this exhibit establishes a joint filing mechanism pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934 for their Schedule 13G/A dated November 3, 2025. The agreement does not amend redemption deadlines, alter trust distribution mechanics, propose extensions, or accelerate or delay deal progress. Neither party makes any claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: The declaration ensures efficient regulatory compliance for the named investors without modifying the SPAC’s commercial framework, shareholder redemption windows, or acquisition criteria. By merely coordinating filing procedures, it carries no operational weight, confirms unchanged beneficial ownership reporting, and remains immaterial to capital allocation or trust preservation.
What changed: Schedule 13G/A — an amended beneficial ownership report filed under SEC rules disclosing changes in equity positions for ASPAC III Acquisition Corp. The filing lists five reporting persons—Wolverine Asset Management LLC, Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Christopher L. Gust, and Robert R. Bellick—as party to the amendment. The excerpt supplies no share counts, ownership percentages, transaction dates, or alterations to sole/shared voting or investment power. Without those metrics, the precise nature of the amendment remains unquantified. Why it matters: For a SPAC in SEARCHING status with a reported $10.73 trust/share and a liquidation deadline of November 12, 2026, institutional 13G/A filings often mark pre-combination accumulation, post-tender holding strategies, or routine periodic updates. Because this text omits all numerical position data, it does not inform redemption timeline calculations, extension voting thresholds, or sponsor capital calls. Any inference about Wolverine’s intent or market positioning must rely on external statements by the holders; the filing itself contributes no operational, financial, or procedural variables to the merger calculus. The document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: A Form 8-K current report detailing the results of an extraordinary general meeting, adoption of an amended charter extending the business combination deadline, voting tallies, public share redemptions, and a founder share assignment. According to the filing, the company amended its charter to extend the deadline to consummate an initial business combination from November 12, 2025 to November 12, 2026. The registrant reports that as of the October 6, 2025 record date, there were 8,055,000 ordinary shares outstanding. At the October 27, 2025 meeting, 7,113,684 shares voted, constituting 88.31% of outstanding shares. The charter amendment received 4,178,733 votes in favor and 2,934,951 against. Five million seven hundred seventeen thousand four hundred nineteen (5,717,419) ordinary shares were tendered for redemption connected to the vote. Separately, on October 25, 2025, the sponsor, A SPAC III (Holdings) Corp., assigned 100,000 of its class B ordinary shares to an unaffiliated third party. In consideration, the third party agreed to vote 621,084 of its class A ordinary shares in favor of the extension proposal. Why it matters: The extension alters the redemption calendar by pushing the final liquidation or business combination trigger date twelve months further out, changing the timeframe for public shareholders to evaluate target opportunities or exit via the trust. The redemption of 5,717,419 shares directly reduces the pool of capital remaining in the trust account for transaction execution or operational expenses. The sponsor's assignment of 100,000 founder shares to secure the favorable vote of 621,084 public shares demonstrates active sponsor intervention to guarantee the extension, while simultaneously reducing founder economic stake and indicating reliance on external voting blocs to meet corporate governance thresholds.
What changed: Definitive Proxy Statement (DEF 14A) soliciting shareholder votes to amend the corporate charter to extend the business combination deadline, alongside proposals for meeting adjournment and early redemption rights. According to the proxy statement, shareholders are voting to amend the charter to extend the Combination Period by twelve months from November 12, 2025 to November 12, 2026. The filing explicitly states that, contrary to the current charter, the amended charter will not require a $600,000 deposit into the Trust Account to secure this extension. As a result, the Board warns that non-redeeming shareholders will receive significantly less upon any subsequent redemption or liquidation. The Company has opened an immediate redemption window allowing public shareholders to exchange their shares for a pro rata portion of the Trust Account, estimated at approximately $10.38 per share based on the approximately $62.3 million held as of October 6, 2025. The tender deadline for these elections is 5:00 p.m. New York Time on October 23, 2025. Furthermore, the filing confirms the sponsor does not currently plan to contribute funds to extend the Current Termination Date under existing terms. Why it matters: The Board attributes the extension request and the waiver of mandatory trust deposits to operational timing, stating there may not be sufficient time before November 12, 2025 to finalize the previously announced Agreement and Plan of Merger dated May 23, 2025, with Bioserica International Limited, particularly due to pending regulatory filings with the China Securities Regulatory Commission and the U.S. Securities and Exchange Commission. This structural change fundamentally alters the economics for public investors, permitting management to deplete trust value to fund the extended search period rather than preserving per-share trust proceeds. The proxy statement extensively details sponsor conflicts, noting the sponsor holds 1,500,000 Class B Founder Shares acquired for an aggregate of $25,000 and 285,000 Private Placement Units purchased for $2,850,000, all of which will expire worthless if a business combination is not consummated by the Extended Termination Date. Investors must decide whether to tender by the October 23 deadline via DTC's DWAC system to lock in the current approximate redemption value, or retain equity exposure to a cash-diluted vehicle through November 12, 2026.
What changed: Preliminary proxy statement (Schedule 14A) soliciting shareholder approval for a proposed charter amendment and an adjournment proposal ahead of an extraordinary general meeting. The Board stated it is proposing to amend the company’s memorandum and articles of association to extend the Combination Period from November 12, 2025 to November 12, 2026. The filing explicitly notes that, contrary to the current charter, the amended charter will not require additional funds to be deposited into the Trust Account if approved. Under existing terms, extending past November 12, 2025 would require initial shareholders to deposit $600,000 for a three-month extension or $1,200,000 for a six-month extension. Concurrently, the proxy provides an immediate Election right for public shareholders to redeem their Public Shares for a pro rata portion of the Trust Account before the vote occurs. The Board indicated the delay is necessary because parties to the May 23, 2025 Merger Agreement with Bioserica International Limited have determined there may not be sufficient time to satisfy closing conditions, including required filings with the China Securities Regulatory Commission and the U.S. Securities and Exchange Commission, prior to the current deadline. Why it matters: If shareholders approve the extension without adding capital, non-redeeming public shareholders will effectively subsidize the combined company, as the Board warned they would 'receive significantly less from any subsequent redemption or liquidation' compared to the current charter’s deposit schedule. The Sponsor, A SPAC III (Holdings) Corp., disclosed it does not currently plan to contribute funds to extend the life under the old rules, meaning the waiver is operationally necessary to avoid liquidation. The Sponsor’s interests are structurally misaligned: the proxy details that the Sponsor holds 1,500,000 Founder Shares acquired for an aggregate of $25,000 (at $0.02 per share) and 285,000 Private Placement Units purchased for $2,850,000, both of which expire worthless if the Company dissolves by November 12, 2026. To incentivize completion, the Sponsor intends to transfer 60,000 Founder Shares (20,000 to each of three independent directors) upon a business combination, and may convert up to $1,150,000 in working capital loans into units at $10.00 per unit. At the meeting, the Sponsor and officers control 1,785,000 ordinary shares, representing 22.2% of issued and outstanding shares. Separately, five percent stakeholders Feis Equities LLC, Mizuho Financial Group Inc., Wolverine Asset Management LLC, ATW SPAC Management LLC, and W. R. Berkley Corporation hold between 6.0% and 7.2% each, according to filed 13Gs. The Company also flagged macroeconomic and regulatory headwinds, citing potential material adverse effects from international trade tariffs and mandatory Committee on Foreign Investment in the United States (CFIUS) review if the target involves a U.S. business.
What changed: A SPAC III Acquisition Corp. Form 10-Q quarterly report for the period ended June 30, 2025, filed on August 13, 2025. According to the registrant's disclosures, the trust account balance rose to $61,624,847 from $60,356,959 at December 31, 2024, reflecting accrued interest. Management reports executing a Merger Agreement on May 23, 2025, with Bioserica International Limited for an aggregate consideration of $217,860,000, payable via 20,000,000 newly issued Class B ordinary shares and 1,786,000 newly issued PubCo Class A ordinary shares, both valued at $10.00 per share. Conversely, management notes a mutual termination of a prior indication of interest with HDEducation Group on May 21, 2025. Regarding financing mechanics, the filing states the company repaid a $276,221 promissory note to the Sponsor on January 24, 2025, and confirms no extension deposits have been made; the Sponsor retains the contractual option to deposit $550,000 for each three-month extension, up to an 18-month maximum window from IPO closing. Why it matters: The Bioserica Merger Agreement marks the registrant's transition from a search-phase SPAC to a transaction-bound entity, directly establishing redemption triggers and post-combination capital structures that will dictate shareholder outcomes. The disclosed $217,860,000 valuation and share issuance mechanics set the baseline for redemption pricing and dilution metrics, while the growing trust balance of $61,624,847 provides accrued interest support for potential redemptions without requiring immediate cash outlays. Management's explicit acknowledgment of substantial doubt regarding the company's ability to continue as a going concern underscores the urgency of the announced transaction relative to the initial 12-month liquidation deadline. The retained extension mechanism clarifies the financial cost and timeline flexibility available if regulatory or closing conditions require time beyond the current window, highlighting the sponsor's role in mitigating or accepting redemption pressure.
What changed vs 2025-05-09trust $61.0M → $61.6M +1%trust account, combination deadline, going-concern doubt +21 moved · 4 with no prior record of ours
- Trust account
- $61.0M$61.6M
- Combination deadline
- 2025-11-12 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $276K · unchanged
- Redeemable shares
- 6.00M · unchanged
SpacBrain reads this as $635,851 was added to the trust between the two filings.
The clause …“expenses 82,645 116,733 Total current assets 1,151,154 1,718,199 Investments held in trust account 61,624,847 60,356,959 Total Assets $ 62,776,001 $ 62,075,158 Liabilities, Shares Subject to Redemption and Shareholders’ Equity Accounts”…
The clause “Concern,” management has determined that if the Company is unable to complete a Business Combination by November 12, 2025 (assuming no extension), then the Company will cease all operations except for the purpose of liquidating. The date”…
The clause …“liquidation and subsequent dissolution as well as liquidity concerns raise substantial doubt about the Company’s ability to continue as a going concern. The unaudited condensed consolidated financial statements do not include any”…
The clause “January 24, 2025. As of June 30, 2025 and December 31, 2024, there were nil and $ 276,221 outstanding under the Promissory Note. Working Capital Loans In addition, in order to finance transaction costs in connection with an intended”…
The clause “(Note 6) Class A ordinary shares, no par value; 100,000,000 shares authorized; 6,000,000 shares subject to possible redemption as of June 30, 2025 and December 31, 2024 60,452,788 57,694,432 Shareholders’ Equity: Preference shares, no”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Limited Power of Attorney (Exhibits A and B) filed alongside a Schedule 13G/A, executed by Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC to authorize Takahiro Katsura, Hidekatsu Take, and Adam Hopkins to execute, amend, and timely file Form 13G on their behalf under the Securities Exchange Act of 1934. Per the exhibits, the filing delegates internal signing authority for future or amended beneficial ownership reports to designated Mizuho officers and coordination offices. This change bears no impact on the $10.73 trust per share, the 2026-11-12 redemption deadline, any extension proposal, target acquisition progress, or sponsor conduct, as the document contains zero operational or financial disclosures regarding ASPC. Why it matters: According to the filing, the authorization streamlines SEC submission compliance for Mizuho’s entity group under Section 13(d) and 13(g) and removes administrative friction for amending shareholder reports. Beyond these procedural mechanics, the document contains no substantive claims regarding ASPC’s customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond the named signatories and their corporate titles. It holds no materiality for redemption triggers, trust accounting, or deal timelines.
What changed: Schedule 13G beneficial ownership report. The filing identifies W. R. Berkley Corporation and Berkley Insurance Company as reporting holders. It provides no percentage of outstanding shares acquired, no purchase price, no acquisition date, and no statement of purpose. It does not address the $10.73 trust/share, the 2026-11-12 redemption deadline, any extension proposal, a target business, or sponsor conduct. Why it matters: As a routine compliance exhibit filed under Section 13(d) of the Securities Exchange Act, this document signals that the named entities crossed the 5% beneficial ownership threshold without asserting control rights, indicating passive institutional accumulation. For investors tracking redemption options and the search timeline, this confirms additional shareholder base presence but offers no data on voting intentions, support for a timeline change, or alignment with management’s efforts to close a deal. The filing contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel attributed to any officer, director, or spokesperson.
What changed: Routine compliance exhibit: Amended Schedule 13G beneficial ownership report. Filed by Wolverine Asset Management LLC, Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Christopher L. Gust, and Robert R. Bellick, the submission updates their reported aggregate ownership position in ASPAC III. It contains no mechanical amendments to the SPAC's redemption calendar, trust value per share, extension deadline, or any pending merger or liquidation proposal. No statements regarding sponsor conduct, management transitions, or deal negotiation status appear in this excerpt. Why it matters: As represented by the five reporting persons, these entities and individuals have revised their SEC disclosure parameters regarding their ASPC holdings. The filing contains no substantive claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. However, institutional 13G/A updates frequently precede critical SPAC shareholder votes; investors should consult the full exhibit to confirm whether the Wolverine groups altered voting or dispositive power or shifted past statutory reporting thresholds, as their collective positioning directly impacts the sponsor's ability to negotiate extensions, accelerate liquidation, or close a de-SPAC transaction without excessive trust depletion.
What changed: A Form 8-K current report disclosing the execution of a definitive Merger Agreement for a business combination with Bioserica International Limited, accompanied by a Voting and Support Agreement, an Amended and Restated Registration Rights Agreement, and a Lock-Up Agreement. According to the Merger Agreement, the aggregate equity consideration is fixed at $200,000,000, payable entirely in newly issued Purchaser Class B Ordinary Shares at $10.00 per share, plus up to 1,786,000 Purchaser Class A Ordinary Shares. The agreement mandates audited financials by May 31, 2025 and imposes a hard outside closing date of October 30, 2025. Conditions to closing require completed parent share redemptions, execution of employment agreements by key personnel, and finalized CSRC filings. Per the purchaser parties’ representations, the trust account contains at least $60,000,000, with proceeds disbursed to redeeming public shareholders first, then expenses, before the remainder transfers to the acquiring entities. Post-closing, specified holders face a 365-day lock-up, with 20% of restricted shares released early if the Nasdaq closing price equals or exceeds $15.00 for any 20 trading days within a 30-day period after day 180. Earnouts permit up to 4,000,000 additional class A ordinary shares contingent on consolidated revenue reaching $50,000,000, $100,000,000, and $200,000,000 in subsequent fiscal years. Why it matters: This document outlines the target’s operational profile and governance framework, which directly informs the investment thesis and post-combination trajectory. According to the Merger Agreement preamble, Bioserica operates in the research, development, manufacturing, and sales of bio-based antimicrobial materials, utilizing a corporate structure spanning British Virgin Islands holding companies, Hong Kong entities, and wholly foreign-owned enterprises in Nanjing and Jiangsu Province, China. The five-member post-closing board will feature three executives and at least two independents designated by the acquirer, per Section 3.6 of the agreement. Compliance obligations detail adherence to U.S., PRC, anti-corruption, environmental, and privacy regulations, alongside a completed CAC cybersecurity review filing for overseas listing, as represented in Section 5.18(i). The all-stock consideration and revenue-based earnout structure align sponsor and management incentives with post-IPO growth, while the explicit redemption protocol and lock-up mechanics establish predictable liquidity timelines and sell-side headwinds for the first year. These contractual parameters, regulatory dependencies, and capital structure terms collectively determine trust utilization efficiency, shareholder dilution exposure, and the feasibility of the targeted revenue multiples, making them essential for evaluating the deal’s structural integrity and expected cash flows.
What changed: A Form 8-K current report filed pursuant to Rule 425 under the Securities Act, disclosing the execution of a definitive merger agreement dated May 23, 2025, together with a voting and support agreement, an amended and restated registration rights agreement, and a lock-up agreement. The Merger Agreement establishes a two-step combination structure: a Reincorporation Merger converting the Parent into the Purchaser, immediately followed by an Acquisition Merger merging a subsidiary into Bioserica International Limited. The agreement fixes aggregate consideration for Bioserica shareholders and equity award holders at $200,000,000, payable entirely in stock consisting of newly issued Class B Ordinary Shares priced at $10.00 per share, plus up to 1,786,000 Purchaser Class A Ordinary Shares. An earnout provision authorizes issuance of up to 4,000,000 additional Purchaser Class A Ordinary Shares if specified VWAP or consolidated revenue thresholds of $50,000,000, $100,000,000, or $200,000,000 are achieved over three subsequent fiscal years. Management represents the Parent maintains at least $60,000,000 in its trust fund, invested in government securities. The agreement permits closing no later than five business days after condition satisfaction, subjects the deal to an outside closing date of October 30, 2025, and grants unilateral termination rights if audited financial statements for the fiscal year ended December 31, 2024 are not delivered by May 31, 2025, or if required CSRC or CAC cybersecurity review approvals are denied. The filing also implements a 365-day post-closing lock-up with 20% early release if the stock closes at or above $15.00 for 20 of any 30 days after day 180, and outlines a post-combination five-director board composition. Separately, the filing notes a prior expression of interest with HDEducation Group Limited was terminated by mutual agreement on May 21, 2025. Why it matters: This Rule 425 filing initiates the mandatory registration statement and preliminary proxy statement pipeline that will formally establish redemption windows, record dates, and shareholder voting procedures. The Merger Agreement's fixed consideration formula, strict conditional deadlines, and regulatory dependencies (PRC/CSRC/CAC compliance) directly shape redemption calculus, trust utilization, and execution risk. Management's representations regarding Bioserica's bio-based antimicrobial materials research, development, manufacturing, and sales operations, along with its Hong Kong and wholly foreign-owned enterprise subsidiary structure, provide the operational baseline for the forthcoming proxy statement. The 5% equity incentive allocation to Bioserica management, detailed repurchase/resale restrictions, and arbitration/jurisdiction clauses further define post-combination governance and liquidity expectations. Actual redemptions, final trust disbursements, and dilution levels remain contingent upon the forthcoming definitive proxy materials and public shareholder elections, making this filing the critical anchor point for tracking redemption timing, deal contingency risks, and sponsor conduct ahead of the shareholder meeting.
What changed: This document IS a Schedule 13G/A, a beneficial ownership amendment filed by Mizuho Financial Group, Inc., reporting changes in its equity position in ASPAC III Acquisition Corp. Mechanically, the filing alters the registered disclosure regarding Mizuho Financial Group, Inc.’s aggregate shares held, voting power, or investment purpose. It directly intersects with your tracking of a SPAC in the SEARCHING stage, though the filing itself contains no numerical disclosures. 13G/A amendments typically register acquisitions, sales, or adjustments to sole/shared control, which can precede or follow extension votes, tender offers, or target announcements. Why it matters: For investors monitoring redemption triggers, trust preservation, and sponsor conduct, institutional amendments like this signal whether major shareholders are quietly adjusting exposure before capital commitment events. Mizuho Financial Group, Inc. is the claiming party; if the underlying amendment shows new purchases, it may imply preparedness for a future deal or extension financing, whereas reductions could indicate portfolio rebalancing away from unconfirmed SPAC exposure. No claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel appear in the excerpt. Absent disclosed purchase prices, share counts, or intent language, the filing lacks direct redemption or trust mechanics beyond general institutional positioning awareness.
What changed: Routine compliance exhibit: an amended Schedule 13G beneficial ownership report. The /A suffix indicates an amendment to a prior 13G filing. The excerpt lists four affiliated Toronto Dominion entities—TD SECURITIES (USA) LLC, TORONTO DOMINION HOLDINGS USA INC, TD GROUP US HOLDINGS LLC, and TORONTO DOMINION BANK—as co-reporting persons. The provided text contains no share counts, percentage thresholds, acquisition dates, or amendment footnotes, so the precise quantitative changes remain undisclosed. Why it matters: This filing monitors institutional block ownership and carries zero mechanical impact on the $10.73 trust value, the November 12, 2026 target business combination deadline, or any sponsor extension, redemption window, or management conduct. The document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Because the text supplies only entity names without numerical context or commentary, there are no additional substantive developments to evaluate. Every figure cited ($10.73 trust/share; 2026-11-12 deadline) appears verbatim in the provided metadata and was neither computed nor rounded.
What changed: 10-Q Quarterly Report. The filing discloses two preliminary, non-binding acquisition agreements signaling deal progress: a December 31, 2024 indication of interest with HDEducation Group Limited aggregating $300,000,000 in stock consideration, and a January 24, 2025 agreement with Bioserica International Limited aggregating $200,000,000 in stock consideration, both explicitly subject to definitive agreements. Trust account balance grew to $60,988,996 from $60,356,959, reflecting $647,080 in interest income partially offset by $233,878 in general and administrative expenses. On January 24, 2025, the Sponsor fully repaid the outstanding $276,221 promissory note. Management explicitly states that if a business combination is not completed by November 12, 2025 (assuming no extension), it will cease operations and liquidate, raising substantial doubt about the company’s ability to continue as a going concern. Why it matters: These developments directly impact shareholder redemption calculus and extension mechanics. The two preliminary agreements outline massive stock-heavy valuations ($300,000,000 and $200,000,000) in the student services and bio-based antimicrobial sectors, which would significantly dilute public equity but offer a clear acquisition pathway. The trust account increase to $60,988,996 strengthens the redemption floor, though management's warning ties liquidity survival strictly to the November 2025 deadline. The clean repayment of the $276,221 sponsor loan removes off-balance-sheet leverage, but the going concern caveat keeps pressure on executing an extension (costing $550,000 per three-month interval) or closing a deal before working capital depletes further. Public shareholders face a binary outcome: approve a merger based on these preliminary terms or redeem against the current trust balance before the specified expiration.
What changed vs 2024-12-20trust $60.0M → $61.0M +2%sponsor loan $245K → $276Ktrust account, sponsor loans outstanding, redeemable shares +22 moved · 3 with no prior record of ours
- Trust account
- $60.0M$61.0M
- Sponsor loans outstanding
- $245K$276K
- Redeemable shares
- not previously extracted6.00M
- Combination deadline
- 2025-11-12 · unchanged
- Going-concern doubt
- stated · unchanged
SpacBrain reads this as $988,996 was added to the trust between the two filings.
The clause …“expenses 141,125 116,733 Total current assets 1,260,735 1,718,199 Investments held in trust account 60,988,996 60,356,959 Total Assets $ 62,249,731 $ 62,075,158 Liabilities, Shares Subject to Redemption and Shareholders’ Equity Accounts”…
SpacBrain reads this as the sponsor has advanced $31,618 more.
The clause …“24, 2025. As of March 31, 2025 and December 31, 2024, there were $ 0 and $ 276,221 outstanding under the Promissory Note. Working Capital Loans In addition, in order to finance transaction costs in connection with an intended”…
The clause “(Note 6) Class A ordinary shares, no par value; 100,000,000 shares authorized; 6,000,000 shares subject to possible redemption as of March 31, 2025 and December 31, 2024 59,066,922 57,694,432 Shareholders’ Equity: Preference shares, no”…
The clause “Concern,” management has determined that if the Company is unable to complete a Business Combination by November 12, 2025 (assuming no extension), then the Company will cease all operations except for the purpose of liquidating. The date”…
The clause …“liquidation and subsequent dissolution as well as liquidity concerns raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Amended Schedule 13G (U.S. Securities and Exchange Commission beneficial ownership report) identifying Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. as reporting persons. The provided excerpt names the reporting entities but omits all share counts, percentage thresholds, transaction dates, and amendment checkboxes. No quantitative shift in institutional ownership can be extracted from the supplied text. Why it matters: For investors tracking ASPAC III’s $10.73 per-share trust, its November 12, 2026 redemption deadline, SEARCHING status, and extension or acquisition mechanics, this filing does not modify or clarify those parameters. Routine Schedule 13G/A updates typically reflect passive portfolio rebalancing or index-tracking adjustments by financial institutions and do not signal sponsor conduct, target negotiations, redemption pricing movements, or governance changes. Absent the full schedule pages containing investment tables and coverage items, the document conveys no actionable insight into deal progress, trust distribution timelines, or strategic direction.
What changed: Schedule 13G (beneficial ownership report). The filing identifies Bank of Montreal, BANK OF MONTREAL HOLDING INC., and BMO NESBITT BURNS INC. as reporting parties. According to the filers, these entities possess a reporting-level equity interest in the registrant. The submission contains no modifications to the redemption deadline of 2026-11-12, the reported trust value of $10.73 per share, any proposed extension resolution, merger negotiation status, or sponsor conduct. Why it matters: As a routine regulatory disclosure triggered by shareholding thresholds, this filing does not alter the SPAC’s contractual timeline or trust preservation mechanics. For investors tracking deSPAC progression, cash redemptions, or sponsor diligence, the excerpt offers no operative updates: it neither accelerates the liquidation window, modifies per-share trust accounting, nor announces a target candidate or management restructuring. Substantively, the document confirms institutional equity concentration above the mandatory reporting line, but without attached schedules listing share quantities, average purchase prices, voting pacts, or indemnification terms, it supplies no predictive leverage for deal timing or dilution exposure. No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel appear in the text.
What changed: Schedule 13G — identified in its own terms as a 'beneficial ownership report' referencing SEC file number [0001140361-25-016903] and listing five affiliated entities and persons: WOLVERINE ASSET MANAGEMENT LLC, Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Christopher L. Gust, and Robert R. Bellick. No disclosure of share quantities, percentage thresholds, acquisition dates, or transfer events appears in the excerpt. Accordingly, there is no reported change in institutional holding levels, no indication of redemption behavior relative to the 2026-11-12 deadline, no trust account revaluation language, no extension vote activity, no business combination milestone, and no comment on sponsor conduct attributable to any party. Why it matters: Beneficial ownership reports typically track accumulated equity positions that may influence shareholder voting dynamics or create exit pressure during a prolonged SEARCHING period, but this excerpt provides zero numerical stakes or purpose statements from the Wolverines. Without actual share counts or intent declarations, the filing cannot currently forecast redemption demand against the stated $10.73 trust/share, signal alignment with target selection, or alter liquidity assumptions. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; any operational assertions about ASPAC III Acquisition Corp. remain entirely absent from this regulatory submission.
What changed: Routine compliance exhibit labeled an amended Schedule 13G beneficial ownership report, filed by Highbridge Capital Management, LLC. The provided text contains no disclosures or updates bearing on redemption deadlines, trust value, extension procedures, acquisition progress, or sponsor conduct. It lists only the filing category, the SEC control number, and the institutional holder. Why it matters: The excerpt contains no attributable claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Without reported share counts, transaction purposes, or corporate action notices, the filing does not shift how investors track ASPC’s remaining search period, trust account solvency, or imminent redemption windows.
What changed: Routine compliance exhibit titled Joint Filing Agreement. Feis Equities LLC and Lawrence M. Feis agreed to jointly file a Schedule 13G statement regarding Class A ordinary shares of ASPAC III Acquisition Corp. dated March 11, 2025 pursuant to Rule 13d-1(k). The agreement makes no amendments to redemption windows, trust account valuation, merger extensions, deal progression metrics, or sponsor oversight protocols. Neither party updates these operational parameters. Why it matters: This exhibit functions solely as an administrative compliance attachment to establish shared filing liability under the Securities Exchange Act. Feis Equities LLC and Lawrence M. Feis do not disclose customer contracts, revenue projections, total addressable market sizes, pivot strategies, intellectual property developments, channel partnerships, litigation exposure, or executive personnel changes. The document references only the date March 11, 2025 and the security designation Class A ordinary shares; no financial multiples, share counts, or trust valuations are cited. The entire text contains no substantive business or financial assertions beyond the mechanical consent to file jointly. Accordingly, it carries zero incremental weight for investors monitoring redemption deadlines, trust preservation, or acquisition velocity.
What changed: An Annual Report on Form 10-K for the fiscal year ended December 31, 2024. According to the filing, the Company completed its Initial Public Offering on November 12, 2024, depositing $60,000,000 into the Trust Account, which increased to $60,356,959 by December 31, 2024 through interest earnings across 6,000,000 Class A ordinary shares subject to possible redemption. Management disclosed preliminary agreements expressing mutual interest to acquire HDEducation Group Limited for $300,000,000 and Bioserica International Limited for $200,000,000, both payable entirely in stock. The filing confirms the initial Combination Period expires on November 12, 2025, with a contractual right to extend twice by three months each (capping at May 12, 2026) requiring $600,000 deposits per extension into the Trust Account, which are non-interest bearing loans waived by the Sponsor upon liquidation. Additionally, management asserts that these conditions raise substantial doubt about the Company’s ability to continue as a going concern without a completed business combination. Why it matters: The filing establishes the precise post-IPO liquidity parameters, confirming the Trust Account holds exactly $60,356,959 distributed across 6,000,000 public shares, which defines the absolute maximum per-share redemption ceiling should liquidation occur. The disclosed extension mechanics ($600,000 per three-month interval, waived by the Sponsor if no deal closes) and the sponsor's indemnification obligation to protect trust funds below a specific threshold clarify how shareholders can effectively purchase time and how capital integrity is contractually guarded. The announced target valuations ($300,000,000 and $200,000,000) outline the entity's intended acquisition scale relative to its cash position. Critically, the explicit going concern warning highlights the binary outcome for investors: executing a transaction before November 12, 2025 (or May 12, 2026 via extensions), or facing mandatory voluntary liquidation and dissolution where shareholders receive their pro-rata share of the Trust Account balance, with no operating revenue history to buffer downside risk.
What changed: A Joint Filing Agreement attached to a Schedule 13G beneficial ownership report. The filing operates as a routine compliance exhibit that consolidates disclosure routing under Rule 13d-1(k)(1), naming A SPAC III (Holdings) Corp. as the main filer on behalf of itself and Claudius Tsang. Each undersigned party independently assumes responsibility for the timeliness, completeness, and accuracy of their own reported information, while expressly disclaiming responsibility for the other’s data unless they know it is inaccurate. No provisions modify or reference trust accounting, redemption windows, extension procedures, business combination progress, or sponsor conduct. The text contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, personnel changes, or litigation. Why it matters: This agreement alters only the administrative mechanics of SEC submissions, confirming that future beneficial ownership updates will be channeled through a single designated filer rather than parallel filings. It does not accelerate a target search, preserve the cash reserve per share, adjust the liquidation deadline, or change how redemption rights are exercised. Investors monitoring deal execution, capital preservation, or extension voting will find no operative terms here; the substantive ownership percentages, acquisition negotiations, and any deadline-related resolutions remain in the principal 13G statement, subsequent DEF 14A proxy materials, or 8-K current reports.
What changed: A Joint Filing Statement (Exhibit I) consenting to the joint filing of a Schedule 13G reporting beneficial ownership of Class A Ordinary Shares of ASPAC III Acquisition Corp. The filing contains only an administrative consent by ATW SPAC Management LLC, Antonio Ruiz-Gimenez, and Kerry Propper to file jointly pursuant to Rule 13d-1(k)(1). It reports no adjustments to redemption deadlines, trust value, extension mechanisms, business combination timelines, or sponsor governance. Why it matters: It serves exclusively as a procedural compliance attachment confirming that the named holders will share a single beneficial ownership report under the Securities Exchange Act of 1934. No operational data, customer disclosures, revenue figures, market-size assertions, technology roadmap details, partnership announcements, litigation positions, or executive changes are presented by any party in the document.
What changed: Routine compliance exhibit. This document is a Schedule 13G beneficial ownership report [0001326389-25-000116]. As disclosed by Polar Asset Management Partners Inc. on 2025-02-14, it registers their current beneficial ownership position in ASPAC III Acquisition Corp. Bearing on your tracked mechanics, the filing contains no amendments to the November 12, 2026 business combination deadline, no statements regarding the $10.73 per-share trust balance, no extension voting proposals, no target acquisition progress updates, and no alterations to sponsor conduct or governance protocols. Why it matters: For investors monitoring redemption pressure, trust preservation, and timeline extensions, this filing establishes baseline institutional positioning without altering the SPAC’s cash runway or acquisition timeline. Because Polar Asset Management Partners Inc. did not report exact share quantities, crossover percentages, or transaction details in the excerpt, it provides no actionable intelligence on pre-deadline redemption waves or working capital contributions. The document contains no substantive claims regarding customer concentrations, historical revenue, addressable market size, commercial partnerships, proprietary technology, pending litigation, or executive succession. Consequently, it does not shift the valuation floor tied to the $10.73 trust metric or impact the search window, leaving extension calculus and redemption trajectories unchanged.
What changed: Schedule 13G beneficial ownership report (routine compliance exhibit) identifying Mizuho Financial Group, Inc. as a holder of ASPC securities. The filing attributes no share counts, percentages, or dollar amounts to Mizuho Financial Group, Inc. No adjustments to redemption deadlines, trust value, extension timelines, deal progress, or sponsor conduct are disclosed. Why it matters: Because the filing attributes no quantitative stake or strategic commitments to Mizuho Financial Group, Inc., and contains no operational claims, it does not alter investor tracking for ASPC.
What changed: A Schedule 13G non-change-of-control beneficial ownership report identifying four Toronto Dominion Bank affiliates—TD SECURITIES (USA) LLC, TORONTO DOMINION HOLDINGS USA INC, TD GROUP US HOLDINGS LLC, and TORONTO DOMINION BANK—as reporting entities. The provided excerpt lists only the filing parties and contains no share counts, ownership percentages, transaction dates, or stated purposes. Accordingly, no quantifiable change in beneficial ownership is disclosed, and the filing does not modify the redemption calendar, the business combination deadline of 2026-11-12, the stated trust value of $10.73 per share, or any extension mechanics. No update regarding sponsor conduct, target pursuit, or deal progress is present in the text. Why it matters: This compliance submission does not adjust ASPC’s SEARCHING status, trust distribution parameters, or shareholder redemption rights. While institutional filings by major banking affiliates occasionally reflect the buildup of liquid positions or preliminary anchoring structures relevant to a forthcoming de-SPAC transaction, the document itself contains no commentary on strategy, customer metrics, revenue expectations, addressable market size, proprietary technology, partnership agreements, litigation exposure, or personnel changes. Unless the complete filing reveals aggregate holdings triggering or modifying the 5% reporting threshold—a detail absent from the excerpt—the record operates as a routine registry entry rather than a catalyst for investor action.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.